Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)-Reference-Cited by-同舟云学术

Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Published:2019-09-20 Issue:2 Volume:55 Page:393-399
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

González-Barca E.^ORCID,Boumendil A.,Blaise D.^ORCID,Trněný M.,Masszi T.,Finel H.,Michieli M. G.,Bittenbring J. T.,Gritti G.,Snowden J. A.,Bishton M.,Bruno B.,de Villambrosia S. González,Janikova A.,Leleu X.,Anagnostopoulos A.^ORCID,Poiré X.^ORCID,Crysandt M.,Özkurt Z. N.,Vandenberghe E.,Itälä-Remes M.,Cahn J. Y.,Jantunen E.,Schroyens W.,Maertens J.,Esquirol A.,Dreger P.,Montoto S.,Sureda A.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-019-0650-x.pdf

Reference25 articles.

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Hematopoietic and lymphoid Tissue. IARC: Lyon 2008.

2. Salar A, Fernández de Sevilla A, Romagosa V, Domingo-Claros A, González-Barca E, de Sanjosé S, et al. Distribution and incidence rates of lymphoid neoplasms according to the REAL classification. A prospective study of 940 cases. Eur J Haematol. 1997;59:231–237.

3. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–242.

4. Pfreundschuh M, Trümper L, Osterborg A, Pettengell R, Trneny M, Imrie K, et al. MabThera International TrialGroup: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7:379–391.

5. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med. 1995;333:1540–1545.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001;Blood;2024-02-01

2. Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma;Current Oncology;2023-12-13

3. The two-step approach to allogeneic hematopoietic stem cell transplantation;Frontiers in Immunology;2023-09-01

4. Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study;Haematologica;2023-08-31

5. CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours;Cells;2023-06-08